Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies

Reperant, 2013, The importance of understanding the human–animal interface, 49 Reperant, 2017, Osterhaus ADME. AIDS, avian flu, SARS, MERS, Ebola, Zika… what next?, Vaccine, 35, 4470, 10.1016/j.vaccine.2017.04.082 Liu, 2016, Virus like particle-based vaccines against emerging infectious disease viruses, Virol Sin, 31, 279, 10.1007/s12250-016-3756-y Qu, 2020, An imperative need for research on the role of environmental factors in transmission of novel coronavirus (COVID-19), Environ Sci Technol, 54, 3730, 10.1021/acs.est.0c01102 De Groot, 2013, Commentary: Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group, J Virol, 87, 7790, 10.1128/JVI.01244-13 Weber, 2016, Am J Infect Control, 44, e91, 10.1016/j.ajic.2015.11.018 World Health Organization. SARS statistics. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Geneva: WHO. Revised on 26 Sep 2003. Available at:https://www.who.int/csr/sars/country/table2004_04_21/en/ [accessed 13 April 2020]. World Health Organization. Statistics on Middle East respiratory syndrome. Geneva: WHO. Published on Nov 2019. Available at:https://www.who.int/emergencies/mers-cov/en/ [accessed 13 April 2020]. 2015 Zumla, 2016, Coronaviruses – drug discovery and therapeutic options, Nat Rev Drug Discov, 15, 327, 10.1038/nrd.2015.37 Denis, 2020, COVID-19 overview of information available to support the development of medical countermeasures and interventions against COVID-19, Transdisciplinary Insights – Living Papers, 1 Woo, 2009, Coronavirus diversity, phylogeny and interspecies jumping, Exp Biol Med, 234, 1117, 10.3181/0903-MR-94 Chan, 2020, Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan, Emerg Microbes Infect, 9, 221, 10.1080/22221751.2020.1719902 Wang, 2020, A novel coronavirus outbreak of global health concern, Lancet, 395, 470, 10.1016/S0140-6736(20)30185-9 2020 Gorbalenya, 2020, Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2, Nat Micro, 5, 536, 10.1038/s41564-020-0695-z Jiang, 2020, A distinct name is needed for the new coronavirus, Lancet, 395, 949, 10.1016/S0140-6736(20)30419-0 2020 2020 Peiris, 2012, Coronaviruses, 587 Fehr, 2015, Coronaviruses: an overview of their replication and pathogenesis, Methods Mol Biol, 1282, 1, 10.1007/978-1-4939-2438-7_1 Singhal, 2020, A review of coronavirus disease-2019 (COVID-19), Indian J Pediatr, 87, 281, 10.1007/s12098-020-03263-6 2020 Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 Rothe, 2020, Transmission of 2019-nCoV infection from an asymptomatic contact in Germany, N Engl J Med, 382, 970, 10.1056/NEJMc2001468 Li, 2020, Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia, N Engl J Med, 382, 1199, 10.1056/NEJMoa2001316 Wang, 2020, Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, China, J Med Virol, 92, 441, 10.1002/jmv.25689 Carlos, 2020, Novel Wuhan (2019-nCoV) coronavirus, Am J Respir Crit Care Med, 201, 7, 10.1164/rccm.2014P7 Rothan, 2020, The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak, J Autoimmun, 109, 10.1016/j.jaut.2020.102433 2020 Wang, 2020, Detection of SARS-CoV-2 in different types of clinical specimens, JAMA, 323, 1843 2020 Lei, 2020, CT imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia, Radiology, 295, 18, 10.1148/radiol.2020200236 Assiri, 2013, Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study, Lancet Infect Dis, 13, 752, 10.1016/S1473-3099(13)70204-4 Phan, 2020, Importation and human-to-human transmission of a novel coronavirus in Vietnam, N Engl J Med, 382, 872, 10.1056/NEJMc2001272 Lu, 2020, Drug treatment options for the 2019-new coronavirus (2019-nCoV), Biosci Trends, 14, 69, 10.5582/bst.2020.01020 Bassetti, 2020, The novel Chinese coronavirus (2019‐nCoV) infections: challenges for fighting the storm, Eur J Clin Invest, 50, e13209, 10.1111/eci.13209 Casanova, 2009, Survival of surrogate coronaviruses in water, Water Res, 43, 1893, 10.1016/j.watres.2009.02.002 Peiris, 2003, Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study, Lancet, 361, 1767, 10.1016/S0140-6736(03)13412-5 Yu, 2004, Evidence of airborne transmission of the severe acute respiratory syndrome virus, N Engl J Med, 350, 1731, 10.1056/NEJMoa032867 Chen, 2020, Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records, Lancet, 395, 809, 10.1016/S0140-6736(20)30360-3 Guo, 2020, The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status, Mil Med Res, 7, 11 Li, 2020, SARS-CoV-2 and viral sepsis: observations and hypotheses, Lancet, 395, 1517, 10.1016/S0140-6736(20)30920-X Cascella, 2020 Devaux, 2020, New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?, Int J Antimicrob Agents, 55, 10.1016/j.ijantimicag.2020.105938 Gautret, 2020, Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, Int J Antimicrob Agents, 10.1016/j.ijantimicag.2020.105949 Colson, 2020, Chloroquine and hydroxychloroquine as available weapons to fight COVID-19, Int J Antimicrob Agents, 55, 10.1016/j.ijantimicag.2020.105932 White, 2014, Malaria, Lancet, 383, 723, 10.1016/S0140-6736(13)60024-0 Boelaert, 2001, The potential place of chloroquine in the treatment of HIV-1-infected patients, J Clin Virol, 20, 137, 10.1016/S1386-6532(00)00140-2 Savarino, 2003, Effects of chloroquine on viral infections: an old drug against today's diseases, Lancet Infect Dis, 3, 722, 10.1016/S1473-3099(03)00806-5 Lee, 2011, The role of antimalarial agents in the treatment of SLE and lupus nephritis, Nat Rev Nephrol, 7, 718, 10.1038/nrneph.2011.150 Rolain, 2007, Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century, Int J Antimicrob Agents, 30, 297, 10.1016/j.ijantimicag.2007.05.015 Burkard, 2014, Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner, PLoS Pathog, 10, 10.1371/journal.ppat.1004502 Vincent, 2005, Chloroquine is a potent inhibitor of SARS coronavirus infection and spread, Virol J, 2, 69, 10.1186/1743-422X-2-69 Taccone, 2020, Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base, Lancet Respir Med, 8, 539, 10.1016/S2213-2600(20)30172-7 Gao, 2020, Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies, Biosci Trends, 14, 72, 10.5582/bst.2020.01047 2020, Chin J Tuberc Respir Dis, 43, 185 Rathi, 2020, Hydroxychloroquine prophylaxis for COVID-19 contacts in India, Lancet Infect Dis, S1473-3099 2020 2020 Alhazzani, 2020, Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19), Intensive Care Med, 46, 1, 10.1007/s00134-020-06022-5 Harrison, 2020, Coronavirus puts drug repurposing on the fast track, Nat Biotech, 38, 379, 10.1038/d41587-020-00003-1 Baidya, 2020, Relevance and role of hydroxychloroquine in prophylaxis and therapy of COVID-19, J Med Sci Clin Res, 8, 94, 10.18535/jmscr/v8i4.18 Varki, 1997, Sialic acids as ligands in recognition phenomena, FASEB J, 11, 248, 10.1096/fasebj.11.4.9068613 Yao, 2020, In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Clin Infect Dis, ciaa237 Götz, 2016, Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import, Sci Rep, 6, 23138, 10.1038/srep23138 Tay, 2013, Nuclear localization of dengue virus (DENV) 1–4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor ivermectin, Antiviral Res, 99, 301, 10.1016/j.antiviral.2013.06.002 Wagstaff, 2012, Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus, Biochem J, 443, 851, 10.1042/BJ20120150 Wagstaff, 2011, An AlphaScreen®-based assay for high-throughput screening for specific inhibitors of nuclear import, J Biomol Screen, 16, 192, 10.1177/1087057110390360 Kosyna, 2015, The importin α/β-specific inhibitor ivermectin affects HIF-dependent hypoxia response pathways, Biol Chem, 396, 1357, 10.1515/hsz-2015-0171 van der Watt, 2016, Targeting the nuclear import receptor Kpnβ1 as an anticancer therapeutic, Mol Can Ther, 15, 560, 10.1158/1535-7163.MCT-15-0052 Caly, 2020, The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro, Antiviral Res, 178, 10.1016/j.antiviral.2020.104787 Timani, 2005, Nuclear/nucleolar localization properties of C-terminal nucleocapsid protein of SARS coronavirus, Virus Res, 114, 23, 10.1016/j.virusres.2005.05.007 Wurm, 2001, Localization to the nucleolus is a common feature of coronavirus nucleoproteins, and the protein may disrupt host cell division, J Virol, 75, 9345, 10.1128/JVI.75.19.9345-9356.2001 Gunalan, 2011, A putative diacidic motif in the SARS-CoV ORF6 protein influences its subcellular localization and suppression of expression of co-transfected expression constructs, BMC Res Notes, 4, 446, 10.1186/1756-0500-4-446 Costanzo, 2020, SARS CoV-2: recent reports on antiviral therapies based on lopinavir/ritonavir, darunavir/umifenovir, hydroxychloroquine, remdesivir, favipiravir and other drugs for the treatment of the new coronavirus, Curr Med Chem, 27, 4536, 10.2174/0929867327666200416131117 Nutho, 2020, Why are lopinavir and ritonavir effective against the newly emerged coronavirus 2019? Atomistic insights into the inhibitory mechanisms, Biochemistry, 59, 1769, 10.1021/acs.biochem.0c00160 Chu, 2004, Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings, Thorax, 59, 252, 10.1136/thorax.2003.012658 Dorward, 2020 Vastag, 2003, Old drugs for a new bug, JAMA, 290, 1695, 10.1001/jama.290.13.1695 Anand, 2003, Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs, Science, 300, 1763, 10.1126/science.1085658 Choy, 2020, Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro, Antiviral Res, 178, 10.1016/j.antiviral.2020.104786 Li, 2020, Therapeutic options for the 2019 novel coronavirus (2019-nCoV), Nat Rev Drug Dis, 19, 149, 10.1038/d41573-020-00016-0 Cao, 2020, A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19, N Engl J Med, 382, 1787, 10.1056/NEJMoa2001282 Li, 2020, An exploratory randomized controlled study on the efficacy and safety of lopinavir/ritonavir or arbidol treating adult patients hospitalized with mild/moderate COVID-19 (ELACOI), MedRxiv Cai, 2020, COVID‐19 in a designated infectious diseases hospital outside Hubei Province, China, Allergy, 0, 1 Hu, 2020, Risk factors associated with clinical outcomes in 323 COVID-19 patients in Wuhan, China, MedRxiv Johnson & Johnson. Lack of evidence to support use of darunavir-based treatments for SARS-CoV-2. 2020. Available at: https://www.jnj.com/lack-of-evidence-to-support-darunavir-based-hiv-treatments-for-coronavirus [accessed 4 April 2020]. Dong, 2020, Discovering drugs to treat coronavirus disease 2019 (COVID-19), Drug Discov Ther, 14, 58, 10.5582/ddt.2020.01012 Sheahan, 2020, Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV, Nat Commun, 11, 1, 10.1038/s41467-019-13940-6 Wang, 2020, Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res, 30, 269, 10.1038/s41422-020-0282-0 Holshue, 2020, First case of 2019 novel coronavirus in the United States, N Engl J Med, 382, 929, 10.1056/NEJMoa2001191 Segler, 2018, Planning chemical syntheses with deep neural networks and symbolic AI, Nature, 555, 604, 10.1038/nature25978 Richardson, 2020, Baricitinib as potential treatment for 2019-nCoV acute respiratory disease, Lancet, 395, e30, 10.1016/S0140-6736(20)30304-4 Sorrell, 2016, Family-wide structural analysis of human numb-associated protein kinases, Structure, 24, 401, 10.1016/j.str.2015.12.015 Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 395, 507, 10.1016/S0140-6736(20)30211-7 Stebbing, 2020, COVID-19: combining antiviral and anti-inflammatory treatments, Lancet Infect Dis, 20, 400, 10.1016/S1473-3099(20)30132-8 Guidelines for the prevention, diagnosis, and treatment of novel coronavirus-induced pneumonia. 5th ed. Available at:http://www.nhc.gov.cn/yzygj/s7653p/202002/d4b895337e19445f8d728fcaf1e3e13a/files/ab6bec7f93e64e7f998d802991203cd6.pdf[accessed 21 April 2020]. Tan, 2004, Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs, Emerg Infect Dis, 10, 581, 10.3201/eid1004.030458 Stockman, 2006, SARS: systematic review of treatment effects, PLoS Med, 3, e343, 10.1371/journal.pmed.0030343 Jianping J, Randomized, open, blank control study on the efficacy and safety of recombinant human interferon α1β; in the treatment of patients with new type of coronavirus infection in Wuhan. Source- U.S. National Library of Medicine. Published on 03 March 2020. Available at: https://clinicaltrials.gov/ct2/show/NCT04293887 [accessed 21 April 2020]. Boriskin, 2008, Arbidol: a broad-spectrum antiviral compound that blocks viral fusion, Curr Med Chem, 15, 997, 10.2174/092986708784049658 Zhao, 2006, Synthesis and in vitro anti-hepatitis B virus activities of some ethyl 5-hydroxy-1H-indole-3-carboxylates, Bioorg Med Chem, 14, 2552, 10.1016/j.bmc.2005.11.033 Xu, 2020, Management of corona virus disease-19 (COVID-19): the Zhejiang experience, J Zhejiang Univ (Med Sci), 49, 147 Deng, 2020, Arbidol combined with LPV/r versus LPV/r alone against corona virus disease 2019: a retrospective cohort study, J Infect, 81, e1, 10.1016/j.jinf.2020.03.002 Zhu, 2020, Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19, J Infect, 81, e21, 10.1016/j.jinf.2020.03.060 Duan, 2020, Effectiveness of convalescent plasma therapy in severe COVID-19 patients, Proc Nat Acad Sci, 4, 168 Cheng, 2005, Use of convalescent plasma therapy in SARS patients in Hong Kong, Eur J Clin Microbiol Infect Dis, 24, 44, 10.1007/s10096-004-1271-9 Ko, 2018, Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience, Antivir Ther, 23, 617, 10.3851/IMP3243 Zhou, 2007, Treatment with convalescent plasma for influenza A (H5N1) infection, N Engl J Med, 357, 1450, 10.1056/NEJMc070359 Mair-Jenkins, 2015, The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis, J Infect Dis, 211, 80, 10.1093/infdis/jiu396 2020 Tanne, 2020, COVID-19: how doctors and healthcare systems are tackling coronavirus worldwide, BMJ, 368, 1090, 10.1136/bmj.m1090 Shen, 2020, Treatment of 5 critically ill patients with COVID-19 with convalescent plasma, JAMA, 323, 1582, 10.1001/jama.2020.4783 Venkateswaran TV, Singh J, India to explore novel blood plasma therapy for COVID-19. New Delhi. Published on 10 April 2020. Available at: https://www.thehindubusinessline.com/news/science/india-to-explore-novel-blood-plasma-therapy-for-covid-19/article31311466.ece [accessed 22 April 2020]. Liu, 2020, Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases, ACS Cent Sci, 6, 315, 10.1021/acscentsci.0c00272 2020 University of Oxford: a study of a candidate COVID-19 vaccine (COV001). Source- U.S. National Library of Medicine. Published on 27 March 2020. Available at: https://clinicaltrials.gov/ct2/show/NCT04324606 [accessed 22 April 2020] Hodgson, 2020, The pandemic pipeline, Nat Biotechnol, 38, 523, 10.1038/d41587-020-00005-z Duddu P. Coronavirus treatment: vaccines/drugs in the pipeline for COVID-19. Available at: https://www.clinicaltrialsarena.com/analysis/coronavirus-mers-cov-drugs/. Published on 16 April 2020. [accessed 22 April 2020]. Ji, 2020, Unique synergistic antiviral effects of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive pulmonary disease, Biomed Pharmacother, 121, 10.1016/j.biopha.2019.109652 2020 Kumar, 2020, Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity, J Biomol Struct Dyn, 1 Morales-Narváez, 2020, The impact of biosensing in a pandemic outbreak: COVID-19, Biosens Bioelectron, 163, 10.1016/j.bios.2020.112274 Zhu, 2020, Learning from large-scale wearable device data for predicting epidemics trend of COVID-19, Discrete Dyn Nat Soc, 2020, 10.1155/2020/6152041 Sharma, 2016, Design of a fluorescence aptaswitch based on the aptamer modulated nano-surface impact on the fluorescence particles, RSC Adv, 6, 65579, 10.1039/C6RA10942J Nawaz, 2018, Development of a portable and disposable NS1 based electrochemical immunosensor for early diagnosis of dengue virus, Anal Chim Acta, 1026, 1, 10.1016/j.aca.2018.04.032 Khan, 2020, Nanobiosensors for virus detection in the environment, 61 Huang, 2016, Fluorescence based aptasensors for the determination of hepatitis B virus antigen, Sci Rep, 6, 31103, 10.1038/srep31103 Mishra, 2015, Ultrasensitive detection of streptomycin using flow injection analysis-electrochemical quartz crystal nanobalance (FIA-EQCN) biosensor, Biosens Bioelectron, 67, 532, 10.1016/j.bios.2014.09.033 Dutra, 2007, An SPR immunosensor for human cardiac troponin T using specific binding avidin to biotin at carboxymethyldextran-modified gold chip, Clin Chim Acta, 376, 114, 10.1016/j.cca.2006.07.029 Du, 2016, Colorimetric aptasensor for progesterone detection based on surfactant-induced aggregation of gold nanoparticles, Anal Biochem, 514, 2, 10.1016/j.ab.2016.09.006 Qiu, 2020, Dual-functional plasmonic photothermal biosensors for highly accurate severe acute respiratory syndrome coronavirus 2 detection, ACS Nano, 14, 5268, 10.1021/acsnano.0c02439 Seo, 2020, Rapid detection of COVID-19 causative virus (SARS-CoV-2) in human nasopharyngeal swab specimens using field-effect transistor-based biosensor, ACS Nano, 14, 5135, 10.1021/acsnano.0c02823